JY
CELU icon

Jeff Yass’s Celularity CELU Stock Holding History

Jeff Yass’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30,200
Closed -$59.2K – 12514
2025
Q2 		$59.2K Sell
30,200
-25,800
-46% -$46.9K ﹤0.01% 12060
2025
Q1 		$96.9K Buy
56,000
+42,700
+321% +$80.9K ﹤0.01% 11561
2024
Q4 		$27.7K Sell
13,300
-4,800
-27% -$11.5K ﹤0.01% 11856
2024
Q3 		$53.8K Sell
18,100
-38,000
-68% -$112K ﹤0.01% 11356
2024
Q2 		$176K Buy
56,100
+21,100
+60% +$73.2K ﹤0.01% 10527
2024
Q1 		$183K Buy
35,000
+6,330
+22% +$26K ﹤0.01% 10697
2023
Q4 		$71.7K Buy
28,670
+80
+0.3% +$174 ﹤0.01% 11536
2023
Q3 		$62.9K Hold
28,590
– – ﹤0.01% 11194
2023
Q2 		$152K Hold
28,590
– – ﹤0.01% 10563
2023
Q1 		$177K Sell
28,590
-25,950
-48% -$209K ﹤0.01% 10741
2022
Q4 		$704K Sell
54,540
-18,370
-25% -$339K ﹤0.01% 7009
2022
Q3 		$1.68M Sell
72,910
-18,390
-20% -$558K ﹤0.01% 5301
2022
Q2 		$3.1M Buy
91,300
+11,000
+14% +$893K ﹤0.01% 3998
2022
Q1 		$6.99M Buy
80,300
+41,310
+106% +$2.48M ﹤0.01% 3083
2021
Q4 		$2M Sell
38,990
-25,610
-40% -$1.64M ﹤0.01% 5506
2021
Q3 		$4.57M Buy
64,600
+36,760
+132% +$2.97M ﹤0.01% 4119
2021
Q2 		$2.83M Sell
27,840
-3,720
-12% -$377K ﹤0.01% 5151
2021
Q1 		$3.18M Buy
+31,560
New +$3.23M ﹤0.01% 4827

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $9.42B AUM 17.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

Jeff Yass's CELU Position: Q1 2026 in Review

Jeff Yass sold out of Celularity (CELU) in Q1 2026, closing a stake of 11,727 shares — an estimated $13K sold.

Jeff Yass first reported a position in CELU in Q4 2020 and held it in 12 quarters. The position peaked at $2.16M in Q1 2022. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2026.

  • Jeff Yass reported no remaining Celularity position as of Q1 2026 after selling out during the quarter.
  • Jeff Yass sold 11,727 Celularity shares in Q1 2026, an estimated $13K.
  • Jeff Yass first reported a position in Celularity in Q4 2020 and held it in 12 quarters.
  • Jeff Yass's Celularity position peaked at $2.16M in Q1 2022.
  • 38 funds tracked by Wall St. Rank held Celularity as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.